4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001415889-25-000879
Options or other derivatives
- Chief Accounting Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Burgess Julie Chief Accounting Officer | 2025-01-02 | Grant or award · Stock option (right to buy) | +135,000 | 135,000 | D: show line 1 in the form |
Loading xslF345X05/form4-01062025_070130.xml…